title: 'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.
abstract: Chronic oral anticoagulant treatment is obligatory in patients (class I) with mechanical heart valves and in patients with atrial fibrillation with CHADS2 score >1. When these patients undergo percutaneous coronary intervention with placement of a stent, there is also an indication for treatment with aspirin and clopidogrel. Unfortunately, triple therapy is known to increase the bleeding risk. For this group of patients, the bottom line is to find the ideal therapy in patients with indications for both chronic anticoagulation therapy and percutaneous intervention to prevent thromboembolic complications such as stent thrombosis without increasing the risk of bleeding. (Neth Heart J 2010;18:444-50.).
authors.affiliation: TweeSteden Hospital, Tilburg, the Netherlands.
authors.forename: W
authors.initials: W
authors.lastname: Dewilde
authors.forename: F W A
authors.initials: FW
authors.lastname: Verheugt
authors.forename: N
authors.initials: N
authors.lastname: Breet
authors.forename: J J
authors.initials: JJ
authors.lastname: Koolen
authors.forename: J M
authors.initials: JM
authors.lastname: Ten Berg